US biopharmaceutical company Insmed has appointed former deputy director of the FDA Dr Eugene Sullivan to be its new chief medical and scientific officer.
Dr Sullivan was most recently vice president of global regulatory affairs at AstraZeneca and prior to that, during a career that has so far spanned more than 20 years focusing on pulmonary and orphan diseases, served at United Therapeutics.
He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.
In his new role Dr Sullivan will report to Will Lewis, president and chief executive officer, who said: “Gene is actively involved as an author, lecturer and advisor on medical and regulatory matters affecting orphan drugs and pulmonary diseases.
“His experience will provide new insight and valuable perspective as we advance Arikayce, INS1009 and our other pipeline candidates while building Insmed into a leading biopharmaceutical company.”